Plasma Soluble Urokinase Plasminogen Activator Receptor and Behçet's Disease .
90 participantsStarted 2021-07-01
Plain-language summary
The purpose of the study is to determine whether plasma levels of the soluble urokinase plasminogen activator(suPAR) can serve as a blood-based biomarker for diagnosis of Behçet's disease and its correlation with disease activity.
Who can participate
Age range
18 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥ 18
* Patients diagnosed as Behçet's disease according to international study group criteria (ICBD ) for diagnosis of Behçet's
Exclusion Criteria:
* Age\< 18 years
* Other autoimmune diseases.
* Pregnancy.
* Acute and chronic systemic infection history.
* The presence of chronic diseases such as chronic renal failure, liver and cardiac failure.
* Presence or history of cancer.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study is measuring something called suPAR — a protein in the blood — in people with Behçet's disease. Can you explain what suPAR is and why its level might be relevant to my condition or my care?
2The recruitment status for this trial is listed as unknown, which could mean it's no longer actively enrolling. Do you know whether this study is still open, and if not, are there similar observational studies on Behçet's disease that I could consider instead?
3This trial appears to be observational, measuring suPAR levels rather than testing a treatment. What would actually happen to me if I participated — would it involve extra blood draws, visits, or changes to my current treatment plan?
4Since this study is measuring a biomarker rather than testing a therapy, how might the findings potentially benefit people with Behçet's disease in the future, even if it doesn't directly change my treatment right now?
5Given that this is a biomarker study with no assigned phase, would participating in it conflict with or complement any standard treatments or other clinical trials you might recommend for managing my Behçet's disease?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
evaluation of the level of suPAR in the study subjects.